{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:24:08Z","timestamp":1769005448482,"version":"3.49.0"},"reference-count":120,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001459","name":"Ministry of Education","doi-asserted-by":"publisher","award":["R154000B70114 and R154000B88112"],"award-info":[{"award-number":["R154000B70114 and R154000B88112"]}],"id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Primary liver cancer is one of the most prevalent and deadly cancers, which incidence continues to increase while treatment response remains poor; thus, in-depth understanding of tumour events is necessary to develop more effective therapies. Animal models for liver cancer are powerful tools to reach this goal. Over the past decade, our laboratory has established multiple oncogene transgenic zebrafish lines that can be robustly induced to develop liver cancer. Histological, transcriptomic and molecular analyses validate the use of these transgenic zebrafish as experimental models for liver cancer. In this review, we provide a comprehensive summary of our findings with these inducible zebrafish liver cancer models in tumour initiation, oncogene addiction, tumour microenvironment, gender disparity, cancer cachexia, drug screening and others. Induced oncogene expression causes a rapid change of the tumour microenvironment such as inflammatory responses, increased vascularisation and rapid hepatic growth. In several models, histologically-proven carcinoma can be induced within one week of chemical inducer administration. Interestingly, the induced liver tumours show the ability to regress when the transgenic oncogene is suppressed by the withdrawal of the chemical inducer. Like human liver cancer, there is a strong bias of liver cancer severity in male zebrafish. After long-term tumour progression, liver cancer-bearing zebrafish also show symptoms of cancer cachexia such as muscle-wasting. In addition, the zebrafish models have been used to screen for anti-metastasis drugs as well as to evaluate environmental toxicants in carcinogenesis. These findings demonstrated that these inducible zebrafish liver cancer models provide rapid and convenient experimental tools for further investigation of fundamental cancer biology, with the potential for the discovery of new therapeutic approaches.<\/jats:p>","DOI":"10.3390\/cancers13205148","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T09:10:49Z","timestamp":1634202649000},"page":"5148","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology"],"prefix":"10.3390","volume":"13","author":[{"given":"Ai Qi","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, National University of Singapore, Singapore 119077, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, National University of Singapore, Singapore 119077, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, National University of Singapore, Singapore 119077, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Liu","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clinre.2017.12.006","article-title":"Molecular bases of the poor response of liver cancer to chemotherapy","volume":"42","author":"Marin","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ko, K.L., Mak, L.Y., Cheung, K.S., and Yuen, M.F. (2020). Hepatocellular carcinoma: Recent advances and emerging medical therapies. F1000Research, 9.","DOI":"10.12688\/f1000research.24543.1"},{"key":"ref_5","unstructured":"Recio-Boiles, A., and Babiker, H.M. (2021). Liver Cancer, StatPearls Publishing LLC."},{"key":"ref_6","unstructured":"Cartner, S.C., Eisen, J.S., Farmer, S.C., Guillemin, K.J., Kent, M.L., and Sanders, G.E. (2020). History of Zebrafish Research. The Zebrafish in Biomedical Research, Academic Press."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nprot.2007.514","article-title":"High-resolution in situ hybridization to whole-mount zebrafish embryos","volume":"3","author":"Thisse","year":"2008","journal-title":"Nat. Protoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2018.07.005","article-title":"A beginner\u2019s guide to understanding and implementing the genetic modification of zebrafish","volume":"138","author":"Rafferty","year":"2018","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-pathol-011110-130330","article-title":"Zebrafish models for cancer","volume":"6","author":"Liu","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-cancerbio-051320-014135","article-title":"Reeling in the Zebrafish Cancer Models","volume":"5","author":"McConnell","year":"2021","journal-title":"Annu. Rev. Cancer Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1101\/gr.144700","article-title":"The syntenic relationship of the zebrafish and human genomes","volume":"10","author":"Barbazuk","year":"2000","journal-title":"Genome Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1546-5098(10)02909-2","article-title":"The zebrafish as a model for human disease","volume":"Volume 29","author":"Perry","year":"2010","journal-title":"Fish Physiology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/817341","article-title":"Think Small: Zebrafish as a Model System of Human Pathology","volume":"2012","author":"Goldsmith","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1172\/JCI60434","article-title":"Hooked! Modeling human disease in zebrafish","volume":"122","author":"Santoriello","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ilar\/ilw040","article-title":"Zebrafish Models of Human Disease: Gaining Insight into Human Disease at ZFIN","volume":"58","author":"Bradford","year":"2017","journal-title":"ILAR J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Evason, K.J., Francisco, M.T., Juric, V., Balakrishnan, S., Lopez Pazmino Mdel, P., Gordan, J.D., Kakar, S., Spitsbergen, J., Goga, A., and Stainier, D.Y. (2015). Identification of Chemical Inhibitors of beta-Catenin-Driven Liver Tumorigenesis in Zebrafish. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005305"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lu, J.W., Liao, C.Y., Yang, W.Y., Lin, Y.M., Jin, S.L., Wang, H.D., and Yuh, C.H. (2014). Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085318"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ccr.2014.01.003","article-title":"UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma","volume":"25","author":"Mudbhary","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lu, J.W., Yang, W.Y., Tsai, S.M., Lin, Y.M., Chang, P.H., Chen, J.R., Wang, H.D., Wu, J.L., Jin, S.L., and Yuh, C.H. (2013). Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076951"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2007.09.007","article-title":"Thioacetamide accelerates steatohepatitis, cirrhosis and HCC by expressing HCV core protein in transgenic zebrafish Danio rerio","volume":"243","author":"Rekha","year":"2008","journal-title":"Toxicology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nprot.2010.8","article-title":"Generation of clonal zebrafish lines and transplantable hepatic tumors","volume":"5","author":"Mizgirev","year":"2010","journal-title":"Nat. Protoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41598-018-19817-w","article-title":"Development of a novel zebrafish xenograft model in ache mutants using liver cancer cell lines","volume":"8","author":"Avci","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2018.12.007","article-title":"An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish","volume":"75","author":"Khan","year":"2019","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jcmgh.2019.05.002","article-title":"There Is Something Fishy About Liver Cancer: Zebrafish Models of Hepatocellular Carcinoma","volume":"8","author":"Wrighton","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mco2.29","article-title":"Transgenic zebrafish for modeling hepatocellular carcinoma","volume":"1","author":"Nakayama","year":"2020","journal-title":"MedComm"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0168-8278(02)00011-9","article-title":"Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality","volume":"36","author":"Li","year":"2002","journal-title":"J. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/toxsci\/kfm183","article-title":"Comparison of mode of action of four hepatocarcinogens: A model-based approach","volume":"99","author":"Groos","year":"2007","journal-title":"Toxicol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/019262330002800512","article-title":"Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N\u2032-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages","volume":"28","author":"Spitsbergen","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/019262330002800511","article-title":"Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages","volume":"28","author":"Spitsbergen","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/01926230490496311","article-title":"Carcinogenic effect of N-nitrosodimethylamine on diploid and triploid zebrafish (Danio rerio)","volume":"32","author":"Mizgireuv","year":"2004","journal-title":"Toxicol. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt1169","article-title":"Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression","volume":"24","author":"Lam","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4161\/cc.5.6.2550","article-title":"Modeling Liver Cancer Using Zebrafish: A Comparative Oncogenomics Approach","volume":"5","author":"Lam","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1242\/dmm.007831","article-title":"A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish","volume":"4","author":"Nguyen","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.3390\/ijms131012153","article-title":"Prognostic and predictive roles of KRAS mutation in colorectal cancer","volume":"13","author":"Arrington","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ijc.28106","article-title":"KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy","volume":"133","author":"Valtorta","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/s41379-020-0560-x","article-title":"KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy","volume":"33","author":"Favazza","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cllc.2012.09.007","article-title":"KRAS mutations in lung cancer","volume":"14","author":"Karachaliou","year":"2013","journal-title":"Clin. Lung Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1309\/AJCPF10ZUNSOLIFG","article-title":"In situ evidence of KRAS amplification and association with increased p21 levels in non-small cell lung carcinoma","volume":"132","author":"Wagner","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lungcan.2011.01.029","article-title":"Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma","volume":"74","author":"Wagner","year":"2011","journal-title":"Lung Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/eci.12441","article-title":"The Ras\/MAPK pathway and hepatocarcinoma: Pathogenesis and therapeutic implications","volume":"45","author":"Delire","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ydbio.2008.04.042","article-title":"Mifepristone-inducible LexPR system to drive and control gene expression in transgenic zebrafish","volume":"320","author":"Emelyanov","year":"2008","journal-title":"Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1242\/dmm.008367","article-title":"An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening","volume":"5","author":"Nguyen","year":"2012","journal-title":"Dis. Models Mech."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Loew, R., Heinz, N., Hampf, M., Bujard, H., and Gossen, M. (2010). Improved Tet-responsive promoters with minimized background expression. BMC Biotechnol., 10.","DOI":"10.1186\/1472-6750-10-81"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1038\/onc.2013.240","article-title":"Crosstalk of Ras and Rho: Activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models","volume":"33","author":"Chew","year":"2014","journal-title":"Oncogene"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jhep.2011.07.025","article-title":"Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish","volume":"56","author":"Li","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_47","first-page":"414","article-title":"A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors","volume":"6","author":"Li","year":"2013","journal-title":"Dis. Models Mech."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Monroe, J.D., Basheer, F., and Gibert, Y. (2021). Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research. Cells, 10.","DOI":"10.3390\/cells10051132"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/cancers3022444","article-title":"Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer","volume":"3","author":"Berasain","year":"2011","journal-title":"Cancers"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/cncr.10963","article-title":"Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray","volume":"95","author":"Wang","year":"2002","journal-title":"Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2125.1996.03748.x","article-title":"Transgenic mouse models in carcinogenesis: Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis","volume":"42","author":"Thorgeirsson","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0006-291X(03)00125-6","article-title":"E2F1 blocks and c-Myc accelerates hepatic ploidy in transgenic mouse models","volume":"302","author":"Conner","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sun, L., Nguyen, A.T., Spitsbergen, J.M., and Gong, Z. (2015). Myc-induced liver tumors in transgenic zebrafish can regress in tp53 null mutation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0117249"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1038\/s41598-017-10529-1","article-title":"Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"77096","DOI":"10.18632\/oncotarget.20357","article-title":"Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish","volume":"8","author":"Yan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"19559","DOI":"10.1038\/srep19559","article-title":"Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras V12 expression in transgenic zebrafish","volume":"6","author":"Nguyen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1541-7786.MCR-19-0759","article-title":"A Novel Zebrafish Model of Metastasis Identifies the HSD11beta1 Inhibitor Adrenosterone as a Suppressor of Epithelial-Mesenchymal Transition and Metastatic Dissemination","volume":"18","author":"Nakayama","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Lu, J.-W., Sun, Y., Lin, L.-I., Liu, D., and Gong, Z. (2021). Exacerbation of Liver Tumor Metastasis in twist1a+\/xmrk+ Double Transgenic Zebrafish Following Lipopolysaccharide or Dextran Sulphate Sodium Exposure. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090867"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1158\/0008-5472.CAN-16-2200","article-title":"Tumor-Associated Neutrophils and Macrophages Promote Gender Disparity in Hepatocellular Carcinoma in Zebrafish","volume":"77","author":"Yan","year":"2017","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"41280","DOI":"10.1038\/srep41280","article-title":"Males develop faster and more severe hepatocellular carcinoma than females in kras(V12) transgenic zebrafish","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jcmgh.2017.01.002","article-title":"Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma","volume":"3","author":"Yang","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Li, Z., Zheng, W., Li, H., Li, C., and Gong, Z. (2015). Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132319"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.28794","article-title":"Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression","volume":"135","author":"Li","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zheng, W., Li, Z., Nguyen, A.T., Li, C., Emelyanov, A., and Gong, Z. (2014). Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091179"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"45796","DOI":"10.1038\/srep45796","article-title":"Chemical inhibition reveals differential requirements of signaling pathways in kras(V12)- and Myc-induced liver tumors in transgenic zebrafish","volume":"7","author":"Yan","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2010.10.011","article-title":"Mitogen-activated protein kinases in hepatocellular carcinoma development","volume":"21","author":"Min","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Wang, W., Smits, R., Hao, H., and He, C. (2019). Wnt\/beta-Catenin Signaling in Liver Cancers. Cancers, 11.","DOI":"10.3390\/cancers11070926"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","article-title":"WNT\/beta-catenin signaling in the development of liver cancers","volume":"132","author":"He","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"632","DOI":"10.21037\/tcr.2016.11.79","article-title":"The p53 family in hepatocellular carcinoma","volume":"5","author":"Kunst","year":"2016","journal-title":"Transl. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.20517\/2394-5079.2017.07","article-title":"Roles of p53 in extrinsic factor-induced liver carcinogenesis","volume":"3","author":"Link","year":"2017","journal-title":"Hepatoma Res."},{"key":"ref_73","first-page":"260","article-title":"TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: Evidence from a meta-analysis","volume":"2","author":"Zhan","year":"2013","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1158\/1078-0432.CCR-18-1254","article-title":"The Role of Angiogenesis in Hepatocellular Carcinoma","volume":"25","author":"Morse","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/1319-3767.37808","article-title":"Sorafenib in the treatment of advanced hepatocellular carcinoma","volume":"14","author":"Mousa","year":"2008","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1021\/pr070063h","article-title":"Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis","volume":"6","author":"Yang","year":"2007","journal-title":"J. Proteome Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyoglu","year":"2013","journal-title":"Hepatology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.18632\/oncotarget.1159","article-title":"Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers","volume":"5","author":"Desai","year":"2014","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0976-9668.82318","article-title":"Immunity over inability: The spontaneous regression of cancer","volume":"2","author":"Jessy","year":"2011","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-07-3293","article-title":"Oncogene addiction","volume":"68","author":"Weinstein","year":"2008","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"dmm039578","DOI":"10.1242\/dmm.039578","article-title":"Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model","volume":"12","author":"Li","year":"2019","journal-title":"Dis. Models Mech."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2019.08.014","article-title":"The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications","volume":"72","author":"Hou","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"HEP17","DOI":"10.2217\/hep-2019-0007","article-title":"The role of the innate immune system in the development and treatment of hepatocellular carcinoma","volume":"7","author":"Roderburg","year":"2020","journal-title":"Hepat. Oncol."},{"key":"ref_85","first-page":"6","article-title":"Immunological characterization of hepatocellular carcinoma","volume":"7","author":"Wang","year":"2021","journal-title":"Hepatoma Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Hall, C., Flores, M.V., Storm, T., Crosier, K., and Crosier, P. (2007). The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish. BMC Dev. Biol, 7.","DOI":"10.1186\/1471-213X-7-42"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1182\/blood-2010-10-314120","article-title":"mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish","volume":"117","author":"Ellett","year":"2011","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2015.03.024","article-title":"Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish","volume":"63","author":"Yan","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1038\/s41598-018-26612-0","article-title":"Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish","volume":"8","author":"Yang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"31952","DOI":"10.1038\/srep31952","article-title":"Enhanced angiogenesis, hypoxia and neutrophil recruitment during Myc-induced liver tumorigenesis in zebrafish","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41598-018-36605-8","article-title":"Transcriptomic profiles of tumor-associated neutrophils reveal prominent roles in enhancing angiogenesis in liver tumorigenesis in zebrafish","volume":"9","author":"Huo","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbrc.2018.12.098","article-title":"Transgenic expression of tgfb1a induces hepatic inflammation, fibrosis and metastasis in zebrafish","volume":"509","author":"Yan","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/s41598-020-80621-6","article-title":"Stimulation of hepatocarcinogenesis by activated cholangiocytes via Il17a\/f1 pathway in kras transgenic zebrafish model","volume":"11","author":"Helal","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_94","first-page":"505","article-title":"Gender difference in patients with hepatocellular carcinoma","volume":"91","author":"Hefaiedh","year":"2013","journal-title":"Tunis Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"66","DOI":"10.20517\/2394-5079.2018.87","article-title":"Gender differences in hepatocellular cancer: Disparities in nonalcoholic fatty liver disease\/steatohepatitis and liver transplantation","volume":"4","author":"Wu","year":"2018","journal-title":"Hepatoma Res."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Natri, H.M., Wilson, M.A., and Buetow, K.H. (2019). Distinct molecular etiologies of male and female hepatocellular carcinoma. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6167-2"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygcen.2019.03.018","article-title":"Effects of sex hormones on liver tumor progression and regression in Myc\/xmrk double oncogene transgenic zebrafish","volume":"277","author":"Li","year":"2019","journal-title":"Gen. Comp. Endocrinol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"10645","DOI":"10.1038\/s41598-019-46378-3","article-title":"Liver-specific androgen receptor knockout attenuates early liver tumor development in zebrafish","volume":"9","author":"Li","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0973-029X.86670","article-title":"Cancer cachexia","volume":"15","author":"Dhanapal","year":"2011","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","article-title":"Oral nutritional interventions in malnourished patients with cancer: A systematic review and meta-analysis","volume":"104","author":"Baldwin","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"988","DOI":"10.18632\/aging.100114","article-title":"Fasting and cancer treatment in humans: A case series report","volume":"1","author":"Safdie","year":"2009","journal-title":"Aging"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cell.2016.05.051","article-title":"Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment","volume":"166","author":"Zhong","year":"2016","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"dmm038240","DOI":"10.1242\/dmm.038240","article-title":"Leptin induces muscle wasting in a zebrafish kras-driven hepatocellular carcinoma (HCC) model","volume":"12","author":"Yang","year":"2019","journal-title":"Dis. Models Mech."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: The role of leptin in human physiology: Emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-811X-8-11","article-title":"Small molecule screening in zebrafish: An in vivo approach to identifying new chemical tools and drug leads","volume":"8","author":"Taylor","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"ref_107","unstructured":"Cartner, S.C., Eisen, J.S., Farmer, S.C., Guillemin, K.J., Kent, M.L., and Sanders, G.E. (2020). Zebrafish as a Platform for Drug Screening. The Zebrafish in Biomedical Research, Academic Press."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bdrc.20208","article-title":"One Step Forward: The Use of Transgenic Zebrafish Tumor Model in Drug Screens","volume":"93","author":"Huang","year":"2011","journal-title":"Birth Defects Res. C"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/d41573-019-00165-x","article-title":"Zebrafish earn their drug discovery stripes","volume":"18","author":"Cully","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","article-title":"Zebrafish disease models in drug discovery: From preclinical modelling to clinical trials","volume":"20","author":"Patton","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","article-title":"Prostaglandin E2 enhances engraftment of human cord blood stem cells and shows long-term safety in preclinical non-human primate transplant models","volume":"8","author":"Goessling","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2013-05-503177","article-title":"Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation","volume":"122","author":"Cutler","year":"2013","journal-title":"Blood"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20180939","article-title":"Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma","volume":"215","author":"Mandelbaum","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10126-019-09889-8","article-title":"Rapid Analysis of Effects of Environmental Toxicants on Tumorigenesis and Inflammation Using a Transgenic Zebrafish Model for Liver Cancer","volume":"21","author":"Yang","year":"2019","journal-title":"Mar. Biotechnol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"113315","DOI":"10.1016\/j.envpol.2019.113315","article-title":"Progression of liver tumor was promoted by tris(1,3-dichloro-2-propyl) phosphate through the induction of inflammatory responses in kras transgenic zebrafish","volume":"255","author":"Chen","year":"2019","journal-title":"Environ. Pollut."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"110220","DOI":"10.1016\/j.ecoenv.2020.110220","article-title":"Promotion effect of liver tumor progression in male kras transgenic zebrafish induced by tris (1, 3-dichloro-2-propyl) phosphate","volume":"191","author":"Chen","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"110962","DOI":"10.1016\/j.envres.2021.110962","article-title":"Perfluorooctane sulfonate promotes doxycycline-induced liver tumor progression in male Kras(v12) transgenic zebrafish","volume":"196","author":"Zhu","year":"2021","journal-title":"Environ. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Argiles","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:14:18Z","timestamp":1760166858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":120,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cancers13205148"],"URL":"https:\/\/doi.org\/10.3390\/cancers13205148","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]}}}